All In Biotech

Drug Trial Radar · NCT07762443

A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata

A Phase I Study to Evaluate the Pharmacokinetics, Safety, and Preliminary Efficacy of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Sep 22, 2026

Primary completion

Dec 30, 2027

Study completion Dec 30, 2027

Sponsor

Sponsor type
Industry
First posted
Aug 13, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 12 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a multicenter, open-label, non-randomized, dose-finding Phase I study designed to evaluate the pharmacokinetics (PK), safety, and preliminary efficacy of VC005 tablets in adolescent subjects with severe alopecia areata (AA).

Conditions

  • Alopecia Areata

Interventions

  • VC005 tabletsDrug

    VC005 repeat administration for 24 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area Under the Curve From Time Zero to Last Quantifiable Concentration(AUC)Time frame: Day1,Day28
  2. Peak Plasma Concentration (Cmax)Time frame: Day1,Day28

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Peking University People's Hospital

    Beijing, Beijing Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.